Altered glycaemia differentially modulates efflux transporter expression and activity in hCMEC/D3 cell line.

about

Impact of cigarette smoke extract and hyperglycemic conditions on blood-brain barrier endothelial cells.BBBomics-Human Blood Brain Barrier Transcriptomics Hub.Uncoupling Protein 2 Inhibition Exacerbates Glucose Fluctuation-Mediated Neuronal Effects.

P2860

Q35884677-E8B940CB-E715-4921-B5F4-EE201DFEDB19 Q38684622-09CD7596-6F01-462C-8CBF-D98973D57B33 Q46311578-3CE022A0-484C-4C84-AFFE-4588457EA548

P2860

Altered glycaemia differentially modulates efflux transporter expression and activity in hCMEC/D3 cell line.

Item

http://www.wikidata.org/entity/Q35685226

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Altered glycaemia differential ...... ctivity in hCMEC/D3 cell line.

@ast

Altered glycaemia differential ...... ctivity in hCMEC/D3 cell line.

@en

type

Item

label

Altered glycaemia differential ...... ctivity in hCMEC/D3 cell line.

@ast

Altered glycaemia differential ...... ctivity in hCMEC/D3 cell line.

@en

prefLabel

Altered glycaemia differential ...... ctivity in hCMEC/D3 cell line.

@ast

Altered glycaemia differential ...... ctivity in hCMEC/D3 cell line.

@en

P1476

Altered glycaemia differential ...... ctivity in hCMEC/D3 cell line.

@en

P2093

Luca Cucullo

http://www.w3.org/2001/XMLSchema#string

Ravi K Sajja

http://www.w3.org/2001/XMLSchema#string

P2860

Diabetes Mellitus and Blood-Brain Barrier Dysfunction: An Overview

P-glycoprotein and breast cancer resistance protein expression and function at the blood-brain barrier and blood-cerebrospinal fluid barrier (choroid plexus) in streptozotocin-induced diabetes in rats.

Drug resistance in brain diseases and the role of drug efflux transporters.

In vitro cerebrovascular modeling in the 21st century: current and prospective technologies.

Alterations in function and expression of ABC transporters at blood-brain barrier under diabetes and the clinical significances.

Downregulation of mdr1a expression in the brain and liver during CNS inflammation alters the in vivo disposition of digoxin.

Altered Nrf2 signaling mediates hypoglycemia-induced blood-brain barrier endothelial dysfunction in vitro.

Glycemic variability: the third component of the dysglycemia in diabetes. Is it important? How to measure it?

Bioluminescent imaging of drug efflux at the blood-brain barrier mediated by the transporter ABCG2

Impact of altered glycaemia on blood-brain barrier endothelium: an in vitro study using the hCMEC/D3 cell line.

P304

59-65

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.NEULET.2015.05.015

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

598

http://www.w3.org/2001/XMLSchema#string

P577

2015-05-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25982326

http://www.w3.org/2001/XMLSchema#string

P932

4456266

http://www.w3.org/2001/XMLSchema#string

Altered glycaemia differentially modulates efflux transporter expression and activity in hCMEC/D3 cell line.

about

P2860

P2860

Altered glycaemia differentially modulates efflux transporter expression and activity in hCMEC/D3 cell line.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P932